Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,103 recalls, newest first

Class II · Moderate risk

AMGEN Kyprolis

Lack of Assurance of Sterility: Potential cracks in glass vials

Terminated Sterility / contamination Amgen, Inc. NDC 76075-102-01 D-0226-2017
Class III · Low risk

Azelastine Hydrochloride Nasal Solution

Defective Delivery System: out of specification result for droplet size distribution at the d90 measurement testing during the 6 month time point..

Terminated Packaging defect Roxane Laboratories, Inc. NDC 0054-0293-99 D-0448-2017
Class I · High risk

Nano PNC Water

Marketed without an Approved NDA/ANDA and non-sterility: NANO PNC Water by nebulizer was sampled and found to contain variovorax paradoxus.

Terminated Sterility / contamination Pacific Medical Solutions D-0505-2017
Class III · Low risk

VirtPrex Prenatal/Postnatal Tablets

cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.

Terminated cGMP deviation Virtus Pharmaceuticals Opco II L NDC 76439-348-30 D-0241-2017
Class I · High risk

SLIMFIT X capsules

Marketed without an approved NDA/ANDA: Product contains undeclared sibutramine and desmethylsibutramine.

Terminated Chemical / undeclared Jersey Shore Supplements, LLC D-0473-2017
Class II · Moderate risk

10% Premasol sulfite-free

Discoloration: there were customer reports of yellow discolored solution. The yellow coloration is the result of oxidation of the amino acid tryptophan due to a damaged overpouch.

Terminated Failed specification Baxter Healthcare Corporation NDC 0338-1130-06 D-0425-2017
Class II · Moderate risk

Fluconazole Injection

Lack of Assurance of Sterility: confirmed customer complaints of leaking bags.

Terminated Sterility / contamination Baxter Healthcare Corporation NDC 0338-6046-48 D-0206-2017
Class III · Low risk

Pentasa (mesalamine)

Presence of Foreign Tablets/Capsules; 500 mg capsules were found in bottles labeled to contain 250 mg capsules

Terminated Particulate / foreign matter Shire PLC NDC 54092-189-81 D-0432-2017
Class I · High risk

MegaJex Herbal Supplement

Marketed without an Approved NDA/ANDA; product contains sildenafil and tadalafil which are active pharmaceutical ingredients in FDA approved drugs used to treat erectile dysfunction (ED)

Terminated Chemical / undeclared MS Bionic D-0472-2017
Class I · High risk

Domperidone capsules 10 mg

Marketed without an approved NDA/ANDA for which safety and efficacy has not been established.

Terminated Unapproved drug Jeffreys Drug Store D-0494-2017
Class III · Low risk

Protonix I.V.

Subpotent Drug: Out of Specification (OOS) for potency at the 6-month stability time point.

Terminated Wrong potency / content Pfizer Inc. NDC 0008-0923-51 D-0516-2017

Recalls by year